Volume 7, Issue 2, March 2019, Page: 61-65
Inhibitory Effect of Ethyl Pyruvate on Orthotopic Transplantation of Gastric Cancer in Severe Combined Immunodeficiency Mice
Tingting Chen, Department of Gastroenterology, Binzhou People's Hospital, Binzhou City, P. R. China
Xiaoxiao Dong, Department of Gastroenterology, Binzhou People's Hospital, Binzhou City, P. R. China
Xiaoyan Zhang, Department of Interventional Operating, Binzhou People's Hospital, Binzhou City, P. R. China
Received: May 29, 2019;       Published: Jul. 29, 2019
DOI: 10.11648/j.ajcem.20190702.14      View  688      Downloads  117
Objective: To investigate the inhibitory effect and mechanism of ethyl pyruvate (EP) on the growth and liver metastasis of orthotopically transplanted gastric cancer in severe combined immunodeficiency (SCID) mice. Methods: SCID mice were orthotopically transplanted with SGC-7901 human gastric cancer tissue to establish a liver metastasis model of gastric cancer. Animals were injected intraperitoneally with different concentrations of EP. After 30 days, gastric cancer and metastatic liver tissues were taken out to detect the volume and weight of gastric cancer tissues and the number of metastatic liver nodules. Real-time quantitative PCR and immunohistochemistry were used to detect high mobility group protein B in different groups. Expression levels of 1 (HMGB1), receptor glycation end product receptor (RAGE), NF-κB, vascular endothelial growth factor (VEGF), and membrane type 1 matrix metalloproteinase (MT1-MMP). Results: Compared with the control group, the weight and size of gastric cancer tissue and the number of metastatic liver nodules in the EP treatment group were significantly reduced (P<0.01). EP inhibited the expression of HMGB1, RAGE, VEGF and MT1-MMP in gastric cancer and metastatic liver tissue, but had no significant effect on NF-κB expression. Conclusion: EP may inhibit the growth of gastric cancer and liver metastasis in SCID mice by down-regulating HMGB1-RAGE pathway, which may have therapeutic effects on cancer.
Severe Combined Immunodeficiency, Orthotopic Transplantation, Gastric Neoplasms, Tumor Metastasis
To cite this article
Tingting Chen, Xiaoxiao Dong, Xiaoyan Zhang, Inhibitory Effect of Ethyl Pyruvate on Orthotopic Transplantation of Gastric Cancer in Severe Combined Immunodeficiency Mice, American Journal of Clinical and Experimental Medicine. Vol. 7, No. 2, 2019, pp. 61-65. doi: 10.11648/j.ajcem.20190702.14
Abadi AT. Kusters JG. et al. Association of inducible nitric oxide synthetase genotype and Helicobacter pylori infection gastric cancer risk may be due to faulty primer design [J]. World J Gastroenterol, 2013, 19(3): 429- 430.
Meng XM. Zhou Y. et al. Magnifying chromoendoscopy combined with immunohistochemical staining for early diagnosis of gastric cancer [J]. World J Gastroenterol, 2013, 19(3): 404-410.
Carneiro F. et al. Hereditary gastric cancer [J]. Pathologe, 2012, 33(2): 231-4.
Song S. Chie EK. et al. Postoperative chemoradiotherapy in high risk locally advanced gastric cancer [J]. Radiat Oncol J, 2012, 30(4): 213-7.
Kim EJ. Seo KW. et al. Laparoscopy-assisted distal gastrectomy for early gastric cancer in the elderly [J]. J Gastric Cancer, 2012, 12(4): 232-6.
Shibata C. Ogawa H. et al. Clinical characteristics of gastric cancer in patients with familial adenomatous polyposis [J]. Tohoku J Exp Med, 2013, 229(2): 143-6.
Nadauld LD. Ford JM. et al. Molecular Profiling of Gastric Cancer: Toward Personalized Cancer Medicine [J]. J Clin Oncol, 2013, 66(18): 515-8.
Wong J. Kelly K. J. et al. Rt-PCR increases detection of submicroscopic peritoneal metastases in gastric cancer and has prognostic significance [J]. J Gastrointest Surg, 2012, 16(5): 889-96.
Jeong JY. Kim MG. et al. Prognostic factors on overall survival in lymph node negative gastric cancer patients who underwent curative resection [J]. J Gastric Cancer, 2012, 12(4): 210-6.
Yan Z. Xiong Y. et al. Identification of recurrence-related genes by combining microRNA and gene expression profiling of gastric cancer [J]. Int J Oncol, 2012, 41(6): 2166-74.
Nam S. Lee J. et al. Differential gene expression pattern in early gastric cancer by an integrative systematic approach [J]. Int J Oncol, 2012, 41(5): 1675-82.
Li ML. Li SG. et al. Differential gene expression profiles of gastric cancer [J]. Zhonghua Yi Xue Za Zhi, 2012, 92(8): 1249-52.
Li ML. Zhang JC. et al. Characteristic gene expression profiles in the progression from normal gastric epithelial cells to moderate gastric epithelial dysplasia and to gastric cancer [J]. Chin Med J (Engl), 2012, 125 (10): 1777-83.
Zhang J. Zhu JS. et al. Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo [J]. Oncol Rep, 2012, 27 (5)): 1511-9.
Zhan Z. Li Q. et al. Autophagy-mediated HMGB1 release antagonizes apoptosis of gastric cancer cells induced by vincristine via transcriptional regulation of Mcl-1 [J]. Autophagy, 2012, 8(1): 109-21.
Song B. Song WG. et al. Effect of HMGB1 silencing on cell proliferation, invasion and apoptosis of MGC-803 gastric cancer cells [J]. Cell Biochem Funct, 2011, 31(11): 642-4.
Chung HW. Lee SG. et al. Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer [J]. J Transl Med, 2009, 7: 38-40.
Aoki T. Nishimura M. et al. PGE(2) -EP(2) signalling in endothelium is activated by haemodynamic stress and induces cerebral aneurysm through an amplifying loop via NF-kappaB [J]. Br J Pharmacol, 2011, 163(6): 1237-49.
Rundhaug JE. Simper MS. et al. The role of the EP receptors for prostaglandin E2 in skin and skin cancer [J]. Cancer Metastasis Rev, 2011, 30(3): 465-80.
Dong Z. Xu X. et al. Leptin-mediated regulation of MT1-MMP localization is KIF1B-dependent and enhances gastric cancer cell invasion [J]. Carcinogenesis, 2013, 19(1): 58-60.
Browse journals by subject